The company is seeking authorisation for a fourth dose of SpikeVax to any adult who has received an initial booster of any of the authorised or approved COVID-19 vaccines. Unlike Pfizer ...

The booster shot – called mRNA-1273.211 ... be good to see data from studies of other variant vaccine boosters to compare to the Moderna combination. Expert advisors "must already be thinking ...

Moderna CEO Stéphane Bancel deflected concerns about the new presidential administration's potential impact on life sciences ...

The president announced a major AI investment project, which Oracle Chairman Larry Ellison said could be used to cure cancer.

A number of High Street chemists and private clinics sell and administer the Pfizer Covid vaccine directly to the public. The ...

The third scenario, in which the booster dose was with the Pfizer vaccine, showed the highest percentages of effectiveness: 56.8% against symptomatic infections and 85.5% against severe cases.

As public health officials monitor a rise in U.S. measles cases, some may be wondering if they need a booster vaccine to protect themselves.

Dr. Adam Ratner joins Morning Joe to discuss his new book 'Booster Shots: The Urgent Lessons of Measles and the Uncertain ...

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the decline of its Covid business.

More than 1,000 people who have sought support from the vaccine damage payment scheme after being injured or bereaved as a ...

The U.S. government has handed Moderna almost $600 million to accelerate its work on various bird flu vaccines as well as work on mRNA vaccines for other influenza strains with pandemic potential.